TLR4 ligation on tumor cells can enhance the secretion of immunosuppressive cytokines and induce resistance to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis [14], [15]. The gene discussed is TLR4; the disease is neoplasm.